Literature DB >> 26140596

Anti-HA Glycoforms Drive B Cell Affinity Selection and Determine Influenza Vaccine Efficacy.

Taia T Wang1, Jad Maamary1, Gene S Tan2, Stylianos Bournazos1, Carl W Davis3, Florian Krammer2, Sarah J Schlesinger4, Peter Palese5, Rafi Ahmed3, Jeffrey V Ravetch6.   

Abstract

Protective vaccines elicit high-affinity, neutralizing antibodies by selection of somatically hypermutated B cell antigen receptors (BCR) on immune complexes (ICs). This implicates Fc-Fc receptor (FcR) interactions in affinity maturation, which, in turn, are determined by IgG subclass and Fc glycan composition within ICs. Trivalent influenza virus vaccination elicited regulation of anti-hemagglutinin (HA) IgG subclass and Fc glycans, with abundance of sialylated Fc glycans (sFc) predicting quality of vaccine response. We show that sFcs drive BCR affinity selection by binding the Type-II FcR CD23, thus upregulating the inhibitory FcγRIIB on activated B cells. This elevates the threshold requirement for BCR signaling, resulting in B cell selection for higher affinity BCR. Immunization with sFc HA ICs elicited protective, high-affinity IgGs against the conserved stalk of the HA. These results reveal a novel, endogenous pathway for affinity maturation that can be exploited for eliciting high-affinity, broadly neutralizing antibodies through immunization with sialylated immune complexes.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26140596      PMCID: PMC4594835          DOI: 10.1016/j.cell.2015.06.026

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  44 in total

Review 1.  The molecular and cellular basis of affinity maturation in the antibody response.

Authors:  G J Nossal
Journal:  Cell       Date:  1992-01-10       Impact factor: 41.582

2.  Engineered glycoforms of an antineuroblastoma IgG1 with optimized antibody-dependent cellular cytotoxic activity.

Authors:  P Umaña; J Jean-Mairet; R Moudry; H Amstutz; J E Bailey
Journal:  Nat Biotechnol       Date:  1999-02       Impact factor: 54.908

3.  The inhibitory Fcgamma receptor modulates autoimmunity by limiting the accumulation of immunoglobulin G+ anti-DNA plasma cells.

Authors:  Hidehiro Fukuyama; Falk Nimmerjahn; Jeffrey V Ravetch
Journal:  Nat Immunol       Date:  2004-12-12       Impact factor: 25.606

4.  Control of recombinant monoclonal antibody effector functions by Fc N-glycan remodeling in vitro.

Authors:  Jason Hodoniczky; Yuan Zhi Zheng; David C James
Journal:  Biotechnol Prog       Date:  2005 Nov-Dec

5.  Effects of repeated annual influenza vaccination on vaccine sero-response in young and elderly adults.

Authors:  W E Beyer; A M Palache; M J Sprenger; E Hendriksen; J J Tukker; R Darioli; G L van der Water; N Masurel; A D Osterhaus
Journal:  Vaccine       Date:  1996-10       Impact factor: 3.641

6.  The roles of gamma 1 heavy chain membrane expression and cytoplasmic tail in IgG1 responses.

Authors:  T Kaisho; F Schwenk; K Rajewsky
Journal:  Science       Date:  1997-04-18       Impact factor: 47.728

7.  Abnormal glycosylation of serum IgG from patients with chronic inflammatory diseases.

Authors:  M Tomana; R E Schrohenloher; W J Koopman; G S Alarcón; W A Paul
Journal:  Arthritis Rheum       Date:  1988-03

8.  Induction of antihemagglutinin antibodies by polyclonal antiidiotype antibodies.

Authors:  L Dinca; S Neuwirth; J Schulman; C Bona
Journal:  Viral Immunol       Date:  1993       Impact factor: 2.257

9.  SHIP recruitment attenuates Fc gamma RIIB-induced B cell apoptosis.

Authors:  R N Pearse; T Kawabe; S Bolland; R Guinamard; T Kurosaki; J V Ravetch
Journal:  Immunity       Date:  1999-06       Impact factor: 31.745

10.  Memory B cells at successive stages of differentiation. Affinity maturation and the role of IgD receptors.

Authors:  L A Herzenberg; S J Black; T Tokuhisa; L A Herzenberg
Journal:  J Exp Med       Date:  1980-05-01       Impact factor: 14.307

View more
  75 in total

Review 1.  The Role and Function of Fcγ Receptors on Myeloid Cells.

Authors:  Stylianos Bournazos; Taia T Wang; Jeffrey V Ravetch
Journal:  Microbiol Spectr       Date:  2016-12

Review 2.  IgG Fc Glycosylation in Human Immunity.

Authors:  Taia T Wang
Journal:  Curr Top Microbiol Immunol       Date:  2019       Impact factor: 4.291

3.  Waning Immunity and Microbial Vaccines-Workshop of the National Institute of Allergy and Infectious Diseases.

Authors:  Xin-Xing Gu; Stanley A Plotkin; Kathryn M Edwards; Alessandro Sette; Kingston H G Mills; Ofer Levy; Andrea J Sant; Annie Mo; William Alexander; Kristina T Lu; Christopher E Taylor
Journal:  Clin Vaccine Immunol       Date:  2017-07-05

4.  Epitope specificity plays a critical role in regulating antibody-dependent cell-mediated cytotoxicity against influenza A virus.

Authors:  Wenqian He; Gene S Tan; Caitlin E Mullarkey; Amanda J Lee; Mannie Man Wai Lam; Florian Krammer; Carole Henry; Patrick C Wilson; Ali A Ashkar; Peter Palese; Matthew S Miller
Journal:  Proc Natl Acad Sci U S A       Date:  2016-10-03       Impact factor: 11.205

Review 5.  Diversification of IgG effector functions.

Authors:  Stylianos Bournazos; Jeffrey V Ravetch
Journal:  Int Immunol       Date:  2017-07-01       Impact factor: 4.823

Review 6.  Extending the Breadth of Influenza Vaccines: Status and Prospects for a Universal Vaccine.

Authors:  Annette Fox; Kylie M Quinn; Kanta Subbarao
Journal:  Drugs       Date:  2018-09       Impact factor: 9.546

Review 7.  The Glycoscience of Immunity.

Authors:  Julie Y Zhou; Douglas M Oswald; Kelsey D Oliva; Lori S C Kreisman; Brian A Cobb
Journal:  Trends Immunol       Date:  2018-05-11       Impact factor: 16.687

Review 8.  Immunological responses to influenza vaccination: lessons for improving vaccine efficacy.

Authors:  Taia T Wang; Stylianos Bournazos; Jeffrey V Ravetch
Journal:  Curr Opin Immunol       Date:  2018-05-10       Impact factor: 7.486

9.  Generation of a Mutant Mucor hiemalis Endoglycosidase That Acts on Core-fucosylated N-Glycans.

Authors:  Toshihiko Katoh; Takane Katayama; Yusuke Tomabechi; Yoshihide Nishikawa; Jyunichi Kumada; Yuji Matsuzaki; Kenji Yamamoto
Journal:  J Biol Chem       Date:  2016-09-14       Impact factor: 5.157

10.  HIV-1 therapy with monoclonal antibody 3BNC117 elicits host immune responses against HIV-1.

Authors:  Till Schoofs; Florian Klein; Malte Braunschweig; Edward F Kreider; Anna Feldmann; Lilian Nogueira; Thiago Oliveira; Julio C C Lorenzi; Erica H Parrish; Gerald H Learn; Anthony P West; Pamela J Bjorkman; Sarah J Schlesinger; Michael S Seaman; Julie Czartoski; M Juliana McElrath; Nico Pfeifer; Beatrice H Hahn; Marina Caskey; Michel C Nussenzweig
Journal:  Science       Date:  2016-05-05       Impact factor: 47.728

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.